Home 2019-12-04T13:30:04+00:00


Consorzio per Valutazioni Biologiche e Farmacologiche (CVBF) is a not-for-profit organisation, founded in 2000 with the mission to perform research and provide scientific, economic and regulatory consultancy for innovation in the health sector at European level. The main fields of interest are life sciences and biotechnologies, drug development for small populations (pediatric and rare diseases), research management andmethodology, monitoring, statistics, regulatory, ethics and pharmacovigilance.


Full services multinational CRO with high expertise in:

  • Regulatory and Pharmacovigilance
  • Trial Management and Monitoring
  • Data Management
  • IP Management

Find out more.

Development and supervision of dossiers and documentation regarding national and European authorisation procedures for medicinal products. Find out more.

Development and management of all clinical trial phases, which are performed by the Consortium both as a Sponsor and as a Contract Research Organisation (CRO). Find out more.

Educational activities addressed to public bodies, research institutes and private companies, also within CME programmes. Find out more.

Management and participation to medical research projects and consortiums at national and international level. Find out more.
Research networks aimed to facilitate transfer of know-how and to promote national and international research as well as scientific excellence. Find out more.
CVBF Brochure

On-going Projects

Latest News

412, 2019

The new Erasmus+ Project Share4Brain will be kicked off very soon!

In December 2019 will start Share4Brain (Sharing Good Practices for Brain Education in Europe), the project funded within the European Programme Erasmus Plus – Strategic partnership for adult education that will be kicked off officially on [...]

212, 2019

CVBF in the list of “2002 Leaders of the Growth” on Sole 24 Ore Journal

  We are glad to announce that Consorzio per Valutazioni Biologiche e Farmacologiche was included in the list of “2020 Leaders of Growth”, realised by Sole 24 Ore and Statista. Among 6000 companies considered, 400 Companies [...]